IDiyas

For the Inventor, By the Inventor

Okazaki, Japan

Fumio Nakano

USPTO Granted Patents = 13

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:

goldMedal13 out of 237 
 
Banyu Pharmaceutical Co. Ltd
 patents

Years Active: 1987-2004

Loading Chart...
13 patents (USPTO):
1. 6790836 - Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates (2004-09-14),
2. 5438054 - 2-(substituted pyrrolidinylthio) carbapenem derivatives (1995-08-01),
3. 5374720 - 2-(substituted pyrrolidinylthio)carbapenem derivatives (1994-12-20),
4. 5373002 - 2-(substituted pyrrolidinylthio) carbapenem derivatives (1994-12-13),
5. 5225406 - 1-carboxy-1-vinyloxyimino aminothiazole cephalosporin derivatives (1993-07-06),
6. 5095013 - 2-(2-vinylpyrrolidinylthio)carbapenem derivatives (1992-03-10),
7. 5084453 - 1-carboxy-1-vinyloxyimino aminothiazole cephalosporin derivatives (1992-01-28),
8. 5068322 - Crystalline cephalosporin compounds (1991-11-26),
9. 5061794 - Cephalosporin derivatives, and antibacterial agents (1991-10-29),
10. 4959469 - Crystalline cephalosporin compounds (1990-09-25),
11. 4883868 - 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives (1989-11-28),
12. 4743609 - Indole derivatives having gastric and antisecretory and cytoprotective (1988-05-10),
13. 4677100 - Cephalosporin derivatives (1987-06-30),

Title: The Innovative Contributions of Fumio Nakano

Introduction

Fumio Nakano, an esteemed inventor based in Okazaki, Japan, has made significant contributions to the field of pharmaceuticals with his innovative approaches. He holds a total of 13 patents, underscoring his active role in advancing scientific research and development.

Latest Patents

Among his latest patents, Nakano has developed a process for preparing indolopyrrolocarbazole derivatives, which are valuable as antitumor agents. This process involves treating a compound with a base in an inert solvent, leading to the production of various intermediates. Moreover, Nakano's work on 2-(substituted pyrrolidinylthio) carbapenem derivatives provides formulations that are useful as antibacterial agents. These inventions demonstrate Nakano's commitment to improving medical therapies through innovative chemical processes.

Career Highlights

Fumio Nakano is currently associated with Banyu Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work primarily focuses on developing new compounds with significant therapeutic potential, contributing to improved health outcomes.

Collaborations

Throughout his career, Nakano has collaborated with prominent colleagues, including Susumu Nakagawa and Ryosuke Ushijima. These partnerships have fostered a creative environment, leading to significant developments in their respective fields.

Conclusion

Fumio Nakano’s dedication to innovation in the pharmaceutical industry is evident through his extensive patent portfolio and collaborative efforts. His inventions not only contribute to scientific knowledge but also hold promise for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…